GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Paincare Holdings Ltd (SGX:FRQ) » Definitions » Debt-to-EBITDA

Singapore Paincare Holdings (SGX:FRQ) Debt-to-EBITDA : 2.16 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Singapore Paincare Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Singapore Paincare Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was S$4.93 Mil. Singapore Paincare Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was S$6.79 Mil. Singapore Paincare Holdings's annualized EBITDA for the quarter that ended in Dec. 2024 was S$5.42 Mil. Singapore Paincare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 2.16.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Singapore Paincare Holdings's Debt-to-EBITDA or its related term are showing as below:

SGX:FRQ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.76   Med: 1.39   Max: 3.88
Current: 2.08

During the past 8 years, the highest Debt-to-EBITDA Ratio of Singapore Paincare Holdings was 3.88. The lowest was 0.76. And the median was 1.39.

SGX:FRQ's Debt-to-EBITDA is ranked better than
55.51% of 454 companies
in the Healthcare Providers & Services industry
Industry Median: 2.38 vs SGX:FRQ: 2.08

Singapore Paincare Holdings Debt-to-EBITDA Historical Data

The historical data trend for Singapore Paincare Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore Paincare Holdings Debt-to-EBITDA Chart

Singapore Paincare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-EBITDA
Get a 7-Day Free Trial 1.38 1.59 1.21 3.88 1.93

Singapore Paincare Holdings Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 9.23 2.03 1.96 2.16

Competitive Comparison of Singapore Paincare Holdings's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Singapore Paincare Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore Paincare Holdings's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Paincare Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Singapore Paincare Holdings's Debt-to-EBITDA falls into.


;
;

Singapore Paincare Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Singapore Paincare Holdings's Debt-to-EBITDA for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.051 + 6.405) / 5.938
=1.93

Singapore Paincare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.928 + 6.792) / 5.418
=2.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2024) EBITDA data.


Singapore Paincare Holdings  (SGX:FRQ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Singapore Paincare Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Singapore Paincare Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore Paincare Holdings Business Description

Traded in Other Exchanges
N/A
Address
601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, and primary care and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company derives its revenue from Singapore.

Singapore Paincare Holdings Headlines

No Headlines